BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

526853

BI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BILCARE LTD. Share Price Update

As of the latest trading session, BILCARE LTD. share price is currently at ₹ 66.2, which is down by ₹ -0.51 from its previous closing. Today, the stock has fluctuated between ₹ 66.12 and ₹ 68.00. Over the past year, BILCARE LTD. has achieved a return of 11.25 %. In the last month alone, the return has been -9.69 %. Read More...

Investment Returns

Over 1 Month -9.69% Over 3 Months -12.62% Over 6 Months 10.46% Over 1 Year 11.25%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BILCARE LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    157.60

  • P/E Ratio (TTM)

    25.46

  • Beta

    1.19

  • Book Value / share

    178.24

  • Return on equity

    -1.65%

  • EPS (TTM)

    2.62

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    3.59

info icon alternate text

BILCARE LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 2.07
Operating Expense 4.30
Net Profit 3.59
Net Profit Margin (%) 173.42
Earnings Per Share (EPS) 1.52
EBITDA 5.31
Effective Tax Rate (%) 20.04
Particulars MAR 2025 (Values in Cr)
Revenue 4.13
Operating Expense 6.35
Net Profit 3.36
Net Profit Margin (%) 81.35
Earnings Per Share (EPS) 1.43
EBITDA 4.87
Effective Tax Rate (%) 20.37
Particulars DEC 2024 (Values in Cr)
Revenue 3.36
Operating Expense 4.78
Net Profit 1.80
Net Profit Margin (%) 53.57
Earnings Per Share (EPS) 0.76
EBITDA 3.25
Effective Tax Rate (%) 23.72
Particulars SEP 2024 (Values in Cr)
Revenue 2.76
Operating Expense 9.30
Net Profit -2.57
Net Profit Margin (%) -93.11
Earnings Per Share (EPS) -1.09
EBITDA 1.05
Effective Tax Rate (%) 6.88
Particulars JUN 2024 (Values in Cr)
Revenue 4.87
Operating Expense 7.08
Net Profit 1.40
Net Profit Margin (%) 28.74
Earnings Per Share (EPS) 0.59
EBITDA 2.98
Effective Tax Rate (%) 14.11
Particulars MAR 2025 (Values in Cr)
Revenue 15.12
Operating Expense 27.52
Net Profit 3.99
Net Profit Margin (%) 26.38
Earnings Per Share (EPS) 1.70
EBITDA 12.17
Effective Tax Rate (%) 26.78
Particulars MAR 2024 (Values in Cr)
Revenue 17.60
Operating Expense 31.35
Net Profit 5.34
Net Profit Margin (%) 30.34
Earnings Per Share (EPS) 2.27
EBITDA 10.34
Effective Tax Rate (%) 6.31
Particulars MAR 2023 (Values in Cr)
Revenue 13.98
Operating Expense 26.09
Net Profit 390.79
Net Profit Margin (%) 2795.35
Earnings Per Share (EPS) 165.97
EBITDA 507.89
Effective Tax Rate (%) 22.29
Particulars MAR 2022 (Values in Cr)
Revenue 429.79
Operating Expense 495.87
Net Profit -17.77
Net Profit Margin (%) -4.13
Earnings Per Share (EPS) -7.55
EBITDA 79.30
Effective Tax Rate (%) 24.47
Particulars MAR 2021 (Values in Cr)
Revenue 304.16
Operating Expense 388.36
Net Profit 1.77
Net Profit Margin (%) 0.58
Earnings Per Share (EPS) 0.75
EBITDA 91.72
Effective Tax Rate (%) 110.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 211.44
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.98
EBITDA Margin 7.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 87.65
ROE % -8.25
ROCE % 2.75
Total Debt to Total Equity 4.72
EBITDA Margin 6.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 31.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 8.47
EBITDA Margin 8.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 36.66
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 7.11
EBITDA Margin 10.79
Particulars MAR 2020 (Values in Cr)
Book Value / Share 45.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 77.39
EBITDA Margin 4.97
Particulars MAR 2024 (Values in Cr)
Book Value / Share 176.54
ROE % -1.65
ROCE % -1.25
Total Debt to Total Equity 0.02
EBITDA Margin -34.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 174.30
ROE % -2.53
ROCE % -1.12
Total Debt to Total Equity 1.54
EBITDA Margin -24.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 18.44
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 13.14
EBITDA Margin 10.64
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.79
ROE % -14.82
ROCE % 0.23
Total Debt to Total Equity 11.57
EBITDA Margin 12.23
Particulars MAR 2020 (Values in Cr)
Book Value / Share 25.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 7.14
EBITDA Margin 3.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 36.42
Total Assets 1567.75
Total Liabilities 1567.75
Total Equity 646.16
Share Outstanding 23545231
Price to Book Ratio 0.32
Return on Assets (%) -2.12
Return on Capital (%) -2.37
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 30.83
Total Assets 1593.38
Total Liabilities 1593.38
Total Equity 703.98
Share Outstanding 23545231
Price to Book Ratio 0.25
Return on Assets (%) 0.94
Return on Capital (%) 1.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 40.07
Total Assets 1126.81
Total Liabilities 1126.81
Total Equity 161.30
Share Outstanding 23545231
Price to Book Ratio 3.79
Return on Assets (%) -1.11
Return on Capital (%) -1.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.63
Total Assets 1064.12
Total Liabilities 1064.12
Total Equity 164.19
Share Outstanding 23545231
Price to Book Ratio 2.24
Return on Assets (%) -1.98
Return on Capital (%) -2.5
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 64.12
Total Assets 1111.55
Total Liabilities 1111.55
Total Equity 176.17
Share Outstanding 23545231
Price to Book Ratio 0.60
Return on Assets (%) -9.31
Return on Capital (%) -11.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.05
Total Assets 460.49
Total Liabilities 460.49
Total Equity 415.65
Share Outstanding 23545231
Price to Book Ratio 0.32
Return on Assets (%) 1.15
Return on Capital (%) 1.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.97
Total Assets 459.82
Total Liabilities 459.82
Total Equity 410.40
Share Outstanding 23545231
Price to Book Ratio 0.25
Return on Assets (%) 84.98
Return on Capital (%) 93.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.52
Total Assets 926.57
Total Liabilities 926.57
Total Equity 43.40
Share Outstanding 23545231
Price to Book Ratio 3.79
Return on Assets (%) -1.91
Return on Capital (%) -2.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.81
Total Assets 928.32
Total Liabilities 928.32
Total Equity 60.71
Share Outstanding 23545231
Price to Book Ratio 2.24
Return on Assets (%) 0.19
Return on Capital (%) 0.24
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.43
Total Assets 972.58
Total Liabilities 972.58
Total Equity 59.17
Share Outstanding 23545231
Price to Book Ratio 0.60
Return on Assets (%) -10.52
Return on Capital (%) -13.33
Particulars MAR 2024 (Values in Cr)
Net Income -65.07
Cash from Operations 63.51
Cash from Investing -105.82
Cash from Financing 35.89
Net change in Cash -7.47
Free Cash Flow 183.07
Particulars MAR 2023 (Values in Cr)
Net Income -30.82
Cash from Operations -3.65
Cash from Investing 36.19
Cash from Financing -18.90
Net change in Cash 10.31
Free Cash Flow -3.65
Particulars MAR 2022 (Values in Cr)
Net Income -33.18
Cash from Operations 47.36
Cash from Investing -4.25
Cash from Financing -54.88
Net change in Cash -17.86
Free Cash Flow 52.07
Particulars MAR 2021 (Values in Cr)
Net Income -51.75
Cash from Operations 71.94
Cash from Investing 1.65
Cash from Financing -82.68
Net change in Cash -9.23
Free Cash Flow 77.96
Particulars MAR 2020 (Values in Cr)
Net Income -270.64
Cash from Operations 376.20
Cash from Investing 1309.37
Cash from Financing -1600.14
Net change in Cash -34.61
Free Cash Flow 376.20
Particulars MAR 2024 (Values in Cr)
Net Income -5.18
Cash from Operations 97.05
Cash from Investing -107.05
Cash from Financing -0.50
Net change in Cash -9.93
Free Cash Flow 212.32
Particulars MAR 2023 (Values in Cr)
Net Income -8.38
Cash from Operations 398.46
Cash from Investing 180.97
Cash from Financing -570.93
Net change in Cash 7.46
Free Cash Flow 398.66
Particulars MAR 2022 (Values in Cr)
Net Income -50.59
Cash from Operations 47.36
Cash from Investing 5.58
Cash from Financing -55.46
Net change in Cash -3.58
Free Cash Flow 48.67
Particulars MAR 2021 (Values in Cr)
Net Income -69.96
Cash from Operations -1.57
Cash from Investing 85.02
Cash from Financing -82.28
Net change in Cash 2.33
Free Cash Flow 0.46
Particulars MAR 2020 (Values in Cr)
Net Income -150.62
Cash from Operations 71.92
Cash from Investing 10.82
Cash from Financing -83.02
Net change in Cash -1.08
Free Cash Flow 72.18
Company Name Price P/E P/B Market Cap 52 Week Low/High
COSMO FIRST LIMITED 1024.40 18.51 1.83 2689.02 532.95 / 1306.85
EPL LIMITED 237.45 19.09 3.22 7599.21 175.50 / 289.70
GARWARE HI-TECH FILMS LTD 3005.90 21.43 2.94 6983.43 2320.05 / 5373.00
AGI GREENPAC LIMITED 948.20 17.62 2.92 6134.61 600.00 / 1300.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
COSMO FIRST LIMITED 1024.40 26.44 2.16 2689.02 532.95 / 1306.85
EPL LIMITED 237.45 37.45 7.39 7599.21 175.50 / 289.70
GARWARE HI-TECH FILMS LTD 3005.90 22.57 3.02 6983.43 2320.05 / 5373.00
AGI GREENPAC LIMITED 948.20 17.62 2.92 6134.61 600.00 / 1300.00

BILCARE LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
66.95 0.35 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 67.00
  • 26 Days 69.20
  • 10 Days 67.50
  • 50 Days 71.20
  • 12 Days 67.70
  • 100 Days 72.30
  • 20 Days 68.60
  • 200 Days 71.30
66.97 PIVOT

First Support

65.94

First Resistance

67.74

Second Support

65.17

Second Resistance

68.77

Third Support

64.14

Third Resistance

69.54

RSI

37.74

ADX

17.66

MACD

-1.57

Williams % R

-83.40

Commodity Channel Index (CCI)

-110.12

Date

2025-08-21

Week

6729.00

Same Day

2694.00

Month

15824.00

1 Year

1.19

3 Year

0.89

Over 1 Month

-9.69%

down

Over 1 Year

11.25%

down

Over 3 Months

-12.62%

down

Over 3 Years

1.89%

down

Over 6 Months

10.46%

down

Over 5 Years

4.88%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

BILCARE LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

BILCARE LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2012 2.0 Final 22 Sep 2012 Equity shares
20 Sep 2011 3.0 Final 22 Sep 2011 Equity shares
23 Sep 2010 2.5 Final 25 Sep 2010 Equity shares
17 Sep 2009 2.5 Final 22 Sep 2009 Equity shares
20 Sep 2007 4.0 Final 24 Sep 2007 Equity shares
15 Sep 2005 0.0 Final 19 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
15 Dec 2003 12 Dec 2003 2:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

BILCARE LTD. Share Price

Bilcare Ltd was incorporated in July, 1987 as Bhandari Paper Products Pvt Ltd and converted into a public limited company on October 27, 1994. The name of the company was changed to BI Ltd in the year 2001 and further the name was changed to Bilcare Ltd on October 1, 2003. The Company is a research-based organization primarily engaged in manufacturing specialty pharmaceutical packaging barrier films. It provides pharmaceutical research services, clinical services and packaging systems and material.

The company's key products include packaging films, aluminum foils, wrap systems, cold formed blisters, closures and containers, and paper composites. They also offer research services, including preformulation studies, formulation development, analytical research, stability studies, packaging audit and packaging development and design. The company's plant at Rajgurunagar in Pune is one of its kinds in Asia and the eighth plant of its kind in the world.

During the year 1997-98, company completed the project of Paper Tube Plant at Patalganga in Maharashtra. During the year 1999-2000, German Investment and Development company namely DEG - Deutsche Investitions - Und Entwicklungsgesellschaft MBH has subscribed to 21% of the share capital of PT Bhandari Mishindo, a subsidiary of the company. During the year 2002-03, the company introduced seven new unique products for the pharma sector namely Nova, Patina, Ultra, Excel, Super Zing and Venus.

During the year 2003-04, the company hived off their Biltube Division in order to focus their core business of manufacture of pharma packaging and research. Also, PT Bhandari Mishindo, a subsidiary company in Indonesia which was formed as an integral part of the Biltube Division was ceased to be a subsidiary of the company. Also, the company promoted Bilcare Singapore Pte Ltd as a wholly owned subsidiary of the company during the year.

In July 2005, Bilcare Singapore Pte Ltd, a wholly owned subsidiary of the company acquired pharma research and clinical services business in USA. Thus Bilcare Inc became a subsidiary of the company. In October 2005, the company unveiled their clinical services facility in Pune. This facility will support the pharma companies in packaging and distribution of their clinical supplies and integrate their global clinical trial requirements efficiently.

In September 2006, the company acquired DHP Ltd, a UK-based Clinical Trials Services provider through Bilcare (UK) Ltd, a wholly owned subsidiary of Bilcare Singapore Pte Ltd. In May 2007, Bilcare Research announced the launch of the Bilcare Research Academy in partnership with Association of Clinical Research Professionals (ACRP), US. The academy shall open 25 centers in India and other parts of Asia by 2010.

In January 2008, Bilcare Singapore has bought 100% of Singular ID, the provider of integrated high technology enterprise brand security system, for a consideration of Singapore Dollar 19.58 million. Bilcare Singapore is a wholly owned subsidiary of the company. In July 2008, Bilcare Ltd and USA based MeadWestvaco Corp jointly acquired the pharmaceutical packaging Company International Labs of St. Petersburg, Florida, USA.

In FY 2013 -14, the Company started commercial production of the specialty cold formable blister (CFB) film on the newly commissioned state of the art multi-layer laminator. The R&D team successfully developed Bilcare Armour' for packaging of highly moisture sensitive formulations in a cost effective manner by replacing conventional high cost material used for packaging of highly moisture sensitive pharmaceutical formulations. Another key R&D activity was the successful development and commercialization of specialty triplex and duplex film laminates comprising PVC/EVOH/Aclar for Oxygen sensitive formulations as well as PVC/PE/Aclar, CPP/Aclar (Polyolefin base) and APET/ Aclar (polyester base) for pharmaceutical applications as green (halogen-free) packaging alternatives. A novel Surlyn based composite film laminate was developed for formulations required to be packaged at low temperatures.

In 2023, the Company transferred its Pharma Packaging Division (PPI) Division as a business undertaking on a going concern basis to its subsidiary, Caprihans India Limited through slump sale, for a net consideration of Rs 213 Crores, on March 27, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1987
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bilcare Ltd?

Answer Field

Bilcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 66.95 as on Aug 22 2025 03:21 PM.

What is the Market Cap of Bilcare Ltd Share?

Answer Field

The market cap of Bilcare Ltd for NSE ₹ 0.00 & for BSE ₹ 157.60 as on Aug 22 2025 03:21 PM.

What is the 52 Week High and Low of Bilcare Ltd?

Answer Field

The 52 Week High and Low of Bilcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 97.99 and ₹ 51.10.

What is 1 year return for Bilcare Ltd?

Answer Field

The 1 year returns on the stock has been 11.25%.

What is the P/E Ratio of Bilcare Ltd Share?

Answer Field

As on Aug 22 2025 03:21 PM the price-to-earnings (PE) ratio for Bilcare Ltd share is 25.46.

What is the PB ratio of Bilcare Ltd Share?

Answer Field

As on Aug 22 2025 03:21 PM, the price-to-book (PB) ratio for Bilcare Ltd share is 178.24.

How to Buy Bilcare Ltd Share?

Answer Field

You can trade in Bilcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bilcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Bilcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bilcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91